All posts
-
Brazilian REE chasers claim processing breakthroughs
BRE states low-temperature procedure confirmed, Meteoric increases recuperations, and Axel obtains ANTSO tick .
-
Boston Dynamics CEO Robert Playter Steps Down
In a memo to staff Tuesday, Boston Dynamics Robert Playter announced that he’s stepping down as CEO, effective straight away. He’ll leave the corporate outright on February 27. The company is for the time being searching for to search out an ethical change, with Amanda McMaster serving as meantime Chief Executive unless the arrangement is
-
Former FDA chief backs Novo Nordic against Hims & Hers: They’ve crossed the line
Previous FDA manager Scott Gottlieb questions that Hims & Hers will certainly be permitted to offer its replica of Novo Nordisk’s weight-loss tablet computer.
-
AstraZeneca expects robust 2026, led by strong cancer drug demand
AstraZeneca anticipates a 2026 support of “mid-high single-digit sales development”.
-
BII expands beyond Denmark: Launches units in UK and Italy
With its European growth, the Bioinnovation Institute (BII) is likewise preparing to establish brand-new funds for international financial investments.
-
Indian drugmakers ready to pounce as Novo Nordisk’s patent expiry looms
According to CNN, 10 business prepare to capitalize on the scenario when semaglutide’s license runs out in India in March.
-
Novo Nordisk working on response after FDA letter about misleading Wegovy ad
Novo Nordisk is functioning to abide by the United States health and wellness authorities.
-
Trump’s new medicine platform starts with just a few drugs
The TrumpRx system supplies just 43 medications, numerous of which have less expensive common options in other places.
-
Coloplast CFO looks forward to welcoming new boss in the spring
The look for a brand-new chief executive officer for Coloplast is proceeding as intended, according to acting chief executive officer Lars Rasmussen on Friday early morning.